Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 22 October 2024, 08:00 HKT/SGT
Share:
    

Source: Femto Technologies Inc
Femto Technologies Inc. Announces Consolidation of Enhanced Voting Preference Shares

Vancouver, BC, Oct 22, 2024 - (NewMediaWire) - Femto Technologies Inc. (Nasdaq: BCAN) (“Femto” or the “Company”), an integrated software company, announces that it has today effected a consolidation (the “Consolidation”) of its issued and outstanding enhanced voting preference shares without par value in the share capital of the Company (the “Enhanced Voting Shares”) on the basis of one post-consolidation Enhanced Voting Share (the “Post-Consolidation Shares”) for every 17 pre-consolidation Enhanced Voting Shares (the “Pre-Consolidation Shares”).

Yftah Ben Yaackov, a director and officer of the Company, is the beneficial owner of all of the issued and outstanding Enhanced Voting Shares.

Early Warning Disclosure

The disclosure in this section is the sole responsibility and is published at the request of Yftah Ben Yaackov, pursuant to his disclosure obligations under National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues (“NI 62-103”).

The requirement to provide this disclosure was triggered by the consolidation on October 21, 2024 of the Enhanced Voting Shares owned by Mr. Yaackov. Pursuant to the Consolidation, the 75,000 Pre-Consolidation Shares were consolidated into 4,412 Post-Consolidation Shares.

Immediately prior to the Consolidation, Mr. Yaackov beneficially owned 75,435 subordinate voting shares in the capital of the Company (the “Subordinate Voting Shares”), representing approximately 11.51% of the issued and outstanding Subordinate Voting Shares, and 75,000 Enhanced Voting Shares, representing 100% of the issued and outstanding Enhanced Voting Shares, representing, in aggregate, approximately 86.84% of the aggregate voting rights attached to all of the Company’s outstanding voting securities. Immediately following the Consolidation, Mr. Yaackov beneficially owned 75,435 Subordinate Voting Shares, representing approximately 11.51% of the issued and outstanding Subordinate Voting Shares, and 4,412 Enhanced Voting Shares, representing 100% of the issued and outstanding Enhanced Voting Shares, representing, in aggregate, approximately 33.80% of the aggregate voting rights attached to all of the Company’s outstanding voting securities; a decrease in the percentage voting rights attached to the voting securities of the Company held by Mr. Yaackov of approximately 53.04%.

The Consolidation was effected to mirror the consolidation of the Subordinate Voting Shares which was effected on August 26, 2024. Mr. Yaackov may from time to time acquire additional securities of the Company or dispose of some or all of the existing or additional securities, whether in transactions over the open market or through privately negotiated arrangements or otherwise, or may continue to hold the same number of securities of the Company. The Enhanced Voting Shares are not transferable by Mr. Yaackov.

A copy of the early warning report filed by Mr. Yaackov pursuant to NI 62-103 may be obtained under the Company’s profile on SEDAR+ (www.sedarplus.ca) and from the Company’s chief financial officer at the contact information provided below. For the purposes of the early warning requirements under NI 62-103, the head office address of the Company is: 2264 East 11th Avenue, Vancouver, BC V5N 1Z6, and the address of Mr. Yaackov is: Eilat 15, Ashkelon, Israel 7844317.

About Femto Technologies Inc.

Femto, previously known as BYND Cannasoft Enterprises Inc., aims to become a beacon of transformative change in the sphere of female health and wellness. Through proprietary Smart Release Technology and a dedication to creating smart, women-centric products, Femto is establishing new benchmarks in the wellness industry.

Femto is an Israeli-based integrated software company. Femto owns and markets “Benefit CRM”, a proprietary customer relationship management (CRM) software product enabling small and medium-sized businesses to optimize their day-to-day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Through a wholly owned subsidiary, Femto owns the patent-pending intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women’s health issues. The EZ-G device includes technological advancements as a sex toy with a more realistic experience and the prototype utilizes sensors to determine what enhances the users’ pleasure. The user can control the device through a Bluetooth app installed on a smartphone or other portable device, with data being transmitted from and received by the device to and from the secure cloud using artificial intelligence (AI). The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction. Commercialization of the EZ-G device is subject to receipt of regulatory approvals.

The devices described in this press release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will ever be marketed.

For further information, please refer to the Company’s new website (www.femtocorp.com) and the Company’s profile on SEDAR+ (www.sedarplus.ca).

Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e-mail: ir@femtocorp.com

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2023 and annual information form dated April 2, 2024, which are available under the company's profile at www.sedarplus.ca, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 3, 2024. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward-looking statements.




Topic: Press release summary
Source: Femto Technologies Inc

Sectors: Healthcare & Pharm, Cannabis
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Femto Technologies Inc
Sept 12, 2024 21:00 HKT/SGT
Femto Technologies Regains Compliance With Nasdaq Minimum Bid Price Requirement
Sept 5, 2024 20:45 HKT/SGT
AI Innovative Award of the 2025 CES Competition to Include Femto Flagship Product
Sept 4, 2024 20:45 HKT/SGT
Femto Partners With FDA-Registered Manufacturer to Launch Flagship AI-Driven FemTech Product's Pods
Sept 3, 2024 19:30 HKT/SGT
Femto's AI-Based Flagship Product to Enter a 3 Stages Consumer Feedback Survey Including a Total of 120 Women
Aug 26, 2024 21:00 HKT/SGT
Femto Technologies Announces 1-for-17 Reverse Stock Split Implemented
Aug 14, 2024 21:00 HKT/SGT
Femto Technologies Reports Increase in Revenue and Transition to Net Profit for the Second Quarter of 2024
July 25, 2024 21:00 HKT/SGT
Femto Pioneering US FemTech to Introduce Flagship Wellness Product at The AVN Expo in Las Vegas
July 22, 2024 21:36 HKT/SGT
BYND CANNASOFT Changes Its Name to Femto Technologies Inc.
July 10, 2024 21:06 HKT/SGT
CEO Periodic Update for 2024 and Review on the Market of the Growing FemTech industry
Apr 8, 2024 20:00 HKT/SGT
BYND Cannasoft Announces RSU Grant
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: